Case 1 | Case 2 | Case 3 | ||
---|---|---|---|---|
WBC (μ/L) | Pretreatment* | 8900 | 9500 | 7650 |
Posttreatment** | 4300 | 4270 | ||
HGB (g/dl) | Pretreatment* | 13.4 | 11.9 | 12.2 |
Posttreatment** | 12.1 | 10.9 | ||
PLT (μ/L) | Pretreatment* | 245,000 | 342,000 | 267,000 |
Posttreatment** | 158,000 | 145,000 | ||
AST (U/L) | Pretreatment* | 34 | 32 | 45 |
Posttreatment* | 53 | 67 | ||
ALT (U/L) | Pretreatment* | 18 | 42 | 54 |
Posttreatment** | 39 | 83 | ||
Creatinine (mg/dl) | Pretreatment* | 0.8 | 1.2 | 0.98 |
Posttreatment* | 0.91 | 1 | ||
Bilirubin total (mg/dl) | Pretreatment* | 0.8 | 1 | 0.98 |
Posttreatment** | 0.89 | 1 |